for Journals by Title or ISSN
for Articles by Keywords
Followed Journals
Journal you Follow: 0
Sign Up to follow journals, search in your chosen journals and, optionally, receive Email Alerts when new issues of your Followed Journals are published.
Already have an account? Sign In to see the journals you follow.
Similar Journals
Canadian Journal of Addiction
Number of Followers: 1  
  Hybrid Journal Hybrid journal (It can contain Open Access articles)
ISSN (Print) 2368-4739
Published by LWW Wolters Kluwer Homepage  [311 journals]
  • Celebrating Leadership in Addiction: Dr Nady el-Guebaly Appointed As
           Member of the Order of Canada
    • Authors: Crockford; David
      Abstract: imageNo abstract available
      PubDate: Sat, 01 Sep 2018 00:00:00 GMT-
  • Examining Barriers as Risk Factors for Relapse: A focus on the Canadian
           Treatment and Recovery System of Care
    • Authors: McQuaid; Robyn J.; Jesseman, Rebecca; Rush, Brian
      Abstract: imageObjectives:In 2016, the Canadian Centre on Substance Use and Addiction (CCSA) conducted the first survey of individuals in recovery from addiction in Canada. The findings revealed that many individuals in recovery lead meaningful lives, contributing to their families and society. However, participants also identified a number of barriers to starting and maintaining recovery. The current study examined the relationship between the barriers experienced and relapse during recovery.Methods:Data from the 2016 Life in Recovery (LIR) from Addiction in Canada survey were analyzed using descriptive and logistic regression analyses. Participants comprised 855 individuals (Mage = 47.3 years), all of whom self-reported being in recovery from addiction.Results:Logistic regressions revealed that upon starting recovery, long delays for treatment, odds ratio (OR) = 1.77, 95% confidence interval (CI) = 1.21–2.60, P 
      PubDate: Sat, 01 Sep 2018 00:00:00 GMT-
  • Towards an On-Site Marijuana Impairment Test (OMIT) for Safety-Sensitive
    • Authors: Els; Charl
      Abstract: No abstract available
      PubDate: Sat, 01 Sep 2018 00:00:00 GMT-
  • Cannabis-Impaired Driving in Canada: Methodological Challenges and
           Emerging Research Priorities
    • Authors: Amlung; Michael
      Abstract: No abstract available
      PubDate: Sat, 01 Sep 2018 00:00:00 GMT-
  • Barriers to Treatment for Substance Use Disorders among Women with
    • Authors: Brogly; Susan B.; Link, Kendra; Newman, Adam; for the Kingston House of Recovery for Women Children
      Abstract: imageObjective:The shortage of treatment options for substance use disorders (SUD) has been further challenged by the opioid crisis. We therefore sought to identify the treatment barriers for an underserved population, women with SUD.Methods:Women with SUD attending methadone/buprenorphine clinics, a healthcare clinic for marginalized populations, and addiction medicine clinic in Kingston and the Kingston area anonymously completed an 11-item questionnaire. The items pertained to the women's substance use and SUD treatment history, barriers to accessing SUD treatment, and missing services. Descriptive frequencies were reported.Results:Sixty-seven women completed the questionnaire, their mean age was 33 years. Most women (70%) had at least 1 child in their care; the mean age of the children was 8.7 years. Thirty women (44.8%) were currently using substances on a regular or semiregular basis. Substances frequently used included opioids (85.1%), marijuana (65.7%), methamphetamines (52.2%), and cocaine (47.8%). Most women (62.5%) had ever participated in a SUD treatment program. A majority also responded that although they had wanted to attend a SUD treatment program at some point in their life they were unable to. Common reasons for not attending a SUD treatment program among women were fear of losing child(ren) (65.9%), no care for child(ren) (48.8%), and waiting list (46.3%). Almost 50% of respondents indicated that parenting resources, parenting skill building programs, parenting support, and childcare were needed services.Conclusions:Expanded and targeted programs for the unique circumstances and childcare needs of women with SUD are warranted.
      PubDate: Sat, 01 Sep 2018 00:00:00 GMT-
  • Narrative Review of Cannabidiol as an Antipsychotic and Recommendations
           for Legal Regulations
    • Authors: Walkey; Lisa Rachel Lena; Tanguay, Robert L.; el-Guebaly, Nady
      Abstract: imageIntroduction:This paper will review the effects of cannabidiol (CBD) in regards to psychosis and schizophrenia, and its purported treatment for psychosis.Methods:A PubMed search was completed using terms: "Cannabidiol and Psychosis," for which 63 studies were found; "Cannabidiol and Schizophrenia," for which 65 studies were found; and "Cannabidiol and Psychotomimetic," for which 37 studies were found. Inclusion criteria included English-language articles published from 2000 to present (July 2016) for human studies only, leading to 7 clinical trials for review. Following this search, 2 additional papers published in 2018 were added for completeness, totaling 9 clinical trials.Results:There have been recent studies showing psychosis is secondary to the tetrahydrocannabinol (THC) in marijuana; more striking is that studies were found showing CBD may be protective and actually have antipsychotic properties equal in efficacy to atypical antipsychotics. THC and CBD seem to have opposite physiologic effects on endogenous anandamide levels and cannabinol receptor binding, the mechanism likely leading to CBD's antipsychotic effect.Conclusions:Early evidence shows that CBD may be a novel and viable treatment for psychosis. This may have an effect on the regulation of CBD and THC percentages in regards to the prevention of early onset schizophrenia.
      PubDate: Sat, 01 Sep 2018 00:00:00 GMT-
  • Diagnosis and Treatment of Comorbid Borderline Personality Disorder and
           Substance Use Disorder
    • Authors: Lahaie; François-Samuel; Fraser, Ronald
      Abstract: Approximately 1% of the general population meets criteria for borderline personality disorder (BPD) diagnosis. In these individuals, the lifetime prevalence of substance use disorder (SUD) is very high. The patients suffering from both BPD and SUD seem to be a more impaired subpopulation. They present with an earlier onset of SUD, an increased addiction severity, and greater impairment in functioning. There is only a small amount of data available on treatment approaches for co-occurring SUD and BPD. Therefore, we decided to present a typical case of a patient presenting with concurrent BPD and SUD and to review the literature of the different treatment approaches available for these patients. In light of the limited data available, it seems that the pharmacological treatment of alcohol use disorder (AUD), in patients suffering from concurrent BPD and AUD, should be considered early in the therapeutic process as the evidence does not show that it less efficacious in this subgroup. We can also affirm that these patients are likely to respond to structured integrative care, including Dialectical Behavioral Therapy for SUD, evidence-based relapse prevention pharmacotherapy for addiction and 12 steps programs. Deconstructive Dynamic Psychotherapy could also be beneficial, but the results of the studies would need to be replicated. Dual-Focus Schema Therapy appeared to offer limited and inconsistent benefits. In this article, we wanted to convey the need for comprehensive approaches, specifically with patients suffering from BPD and SUD, who tend to be marginalized.
      PubDate: Sat, 01 Sep 2018 00:00:00 GMT-
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
Home (Search)
Subjects A-Z
Publishers A-Z
Your IP address:
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-